{"id":16993,"date":"2020-10-20T07:53:00","date_gmt":"2020-10-20T11:53:00","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16993"},"modified":"2020-10-20T07:53:00","modified_gmt":"2020-10-20T11:53:00","slug":"a-big-alzheimers-drug-study-is-proceeding-cautiously-despite-the-pandemic","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16993","title":{"rendered":"A Big Alzheimer&#8217;s Drug Study Is Proceeding Cautiously, Despite The Pandemic"},"content":{"rendered":"<p>(By Jon Hamilton for NPR)<\/p>\n<p>Medical research was an early casualty of the COVID-19 pandemic.<\/p>\n<p>After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now, some researchers are finding ways to carry on in spite of the coronavirus.\u00a0 Continue reading article <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2020\/10\/20\/925493843\/a-big-alzheimers-drug-study-is-proceeding-cautiously-despite-the-pandemic\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3902\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" width=\"152\" height=\"55\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Jon Hamilton for NPR) Medical research was an early casualty of the COVID-19 pandemic. After cases began emerging worldwide,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-16993","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16993"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16993\/revisions"}],"predecessor-version":[{"id":16994,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16993\/revisions\/16994"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}